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T-cells and macrophages in rapidly progressive glomerulonephritis:
Clinicopathologic correlations. We phenotyped with monoclonal anti-
bodies (MAb) the cellular infiltrates in kidneys of patients with rapidly
progressive glomerulonephritis (RPGN) responsive (R) or nonrespon-
sive (NR) to pulse methyiprednisolone therapy (PM)-eight anti-GBM,
six no immune deposits, three immune complex, two vasculitis, and one
proliferative GN. There were glomerular, periglomerular, crescentic,
and interstitial T and 1-cell subsets. Few interstitial and no glomerular
B and NK cells were observed. T11 cells were much more common than
T5. Phenotypes were quantitatively evaluated in 221 nephritic and 32
control glomeruli. I and/or TH cells were positively correlated with
Ml, r = 0.30 to 0.74, P < 0.05 to 0.0005. Although differences in
phenotypes were observed, these differences were insufficient to dis-
tinguish between subtypes. Analysis of R and NR revealed no relation-
ship to percent crescents, entry serum creatinine, oliguria, or need for
dialysis. NR was related to presence of anti-GBM disease, P = 0.001,
as was ability to stop dialysis, 0 of 7 GBM versus 9 of 10 other, P <
0.001. Mild infiltrates of lymphocytes and M1' correlated with R, P 
0.02. R had fewer numbers of TH and M1 in glomeruli, P = 0.0001, in
crescents, P < 0.02, and total TH and M1 compared to NR, P <0.001.
Crescentic and total TH/S ratios were lower in NR than R, P < 0.05.
These findings demonstrate that components of the cell-mediated
immune (CMI) system are present by MAb analysis, that subtypes
cannot be differentiated by CMI constitution, and R to PM is related to
intensity and composition of CMI involvement. Independence of the
CMI system relative to anti-GBM disease remains to be clarified.
Rapidly progressive glomerulonephritis (RPGN) is a clinical
syndrome of rapid decrease in kidney function associated with
glomerulonephritis (GN) [1—3]. The UN may be characterized
by proliferation of the glomerular tuft only, by the formation of
acute crescents, or by proliferation of the tuft with crescents.
Antibody mediated mechanisms appear to be responsible for
much of the pathogenesis of the disease and include: (1)
antibodies directed against the glomerular basement membrane
(GBM); (2) "in situ" immune complexes (IC); and (3) deposi-
tion of circulating soluble IC [4]. Many patients will have GN in
the absence of significant detectable immune reactants within
glomeruli [5]. Nonetheless, the histologic appearances of these
various types of acute crescentic RPGN (AC-RPGN) are quite
similar. Histologic findings common to various types of RPGN
include the presence of a mononuclear cell interstitial infiltrate
of varying intensity, gaps in Bowman's basement membrane,
and the occurrence of multinucleated giant cells. Increasing
evidence from experimental animal models and man suggests a
role for cell mediated immunity (CMI) in concert with antibody-
mediated immune mechanisms to produce disease, and as a
pathogenic process which can occur in the absence of overt
antibody-mediated immunity [4]. Indeed, the histologic appear-
ance of RPGN is so similar to that seen in cell mediated renal
allograft rejection that this has served as a rationale for therapy
[61. This was based on the hypothesis that delayed-type hyper-
sensitivity reactions similar to acute allograft rejection might be
operative. The purpose of the present study was (1) to further
investigate a possible role for CMI in the pathogenesis of these
diseases utilizing morphologic methods, and (2) to correlate
these findings with the clinical course and responsivity of the
disease to pulse methylprednisolone therapy, a modality effec-
tive both for cell mediated acute allograft rejection and for
certain types of RPGN.
Methods
Selection of patients
This retrospective study was comprised of patients who fit
the clinical criteria for RPGN, who had received pulse methyl-
prednisolone therapy, and who had tissue available for re-
evaluation of the light microscopic appearance and for resec-
tioning and staining with monoclonal antibodies for various
components of the CMI system [1, 2, 6]. RPGN was defined by
the presence of GN associated with a doubling of the serum
creatinine or halving of the creatinine clearance within a three
month period of time. Therapy consisted of intravenous admin-
istration of methylprednisolone, 30 mg/kg over 20 minutes, up
to 3 g maximum at one dose. This was repeated every other day
for three doses, and patients then started on high dose, alternate
day prednisone. One patient with anti-GBM disease who did
not respond to pulse therapy received plasma exchange, with-
out response. Other patients were not plasma exchanged.
Patients were considered to be responders to pulse methyipred-
nisolone therapy if they discontinued dialysis, had a 30%
decrease in serum creatinine or 30% increase in creatinine
clearance [6]. In order to be included, information also had to
be available regarding the course of the patients and follow up.
Histology
In addition to routine immunofluorescence, light and electron
microscopy, snap frozen portions of renal tissue were pro-
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cessed for evaluation of cellular infiltrates using monoclonal
antibodies. Tissue was sectioned at 4 micrometers in thickness,
placed on gelatinized slides and air dried overnight. The tissue
sections were fixed in cold acetone at 40 C for two minutes
immediately prior to staining with an avidin-biotin-immunoper-
oxidase technique [7]. The sections were hydrated in 0,1 M
phosphate buffered saline (PBS). Endogenous biotin activity
was blocked with avidin D (15 mm) followed by biotin (15 mm)
(Vector Laboratories, Inc., Burlingame, California, USA). This
was followed by sequential 30 minute incubations with non-
immune horse serum; 1:10 dilutions of appropriate primary
mouse antihuman monoclonal antibodies (Becton Dickinson,
Mountain View, California, USA); a 1:400 dilution of biotin
conjugated horse-antimouse secondary antibody, and an avidin-
biotin-horseradish peroxidase complex (Vector Laboratories).
Monoclonal antibodies used and cells bearing the antigen were,
respectively: Leu-l, T-lymphocyte, associated; Leu-4, T lym-
phocytes, specific; Leu-2, T cytotoxic/suppressor lymphocytes;
Leu-3, T helper/inducer lymphocytes; Leu- 11, natural killer
cells; Leu- 14, B lymphocytes; Leu-M1, monocytes and granu-
locytes; and Leu-M3, moncytes/macrophages [8—10]. The sec-
tions were developed with 0.1% diaminobenzidine substrate,
(Sigma Diagnostics, St. Louis, Missouri, USA) in 0.1 M PBS pH
7.4 and 0.02% H202. Mayer's hematoxylin was used as a
counterstain. All washing between steps was carried out with
PBS. Normal tonsil tissue served as positive controls. Negative
controls included omission of the primary antibody and the use
of similar Ig-class mouse antibodies against nonrelevant anti-
gens. Similar areas of consecutive sections were examined and
compared. Infiltrates were graded as mild, moderate, or severe.
T to B lymphocyte ratios and the ratio of helper/suppressor
cells were estimated from these sections, The light microscopic
analyses were performed on H&E sections with quantitation of
cellular infiltrates on a 0 to 4+ basis. There were five or more
glomeruli/section for light microscopy, and three or more for
monoclonal antibody analysis.
Quantitative cellular analysis
For quantitative analysis of cells in glomeruli and crescents,
sections were examined for T and B cells and macrophages. A
diagram was drawn of each section identifying the location of
each glomerulus. Each individual glomerulus with its crescent,
if present, was examined and the number of positive cells
present in the tuft and crescent was counted. Cells had to be
clearly in the capillary tuft and outside of crescents to be
counted as "glomerular." Cells clearly within crescents and not
definitely in the tuft were counted as "crescentic." For
comparison/correlations, the cells had to occur in the same
glomerulus. The monoclonal antibody studies were performed
and read by one of the authors (DJI) and the light and micro-
scopic sections by another (BCS). Neither pathologist was
aware of the findings of the other nor of the clinical course of
the patients.
Statistical analysis
Data were analyzed by SAS programs. These included the
Fisher's exact test, Student's t-test, analysis of variance with
the Duncan's multiple range test, Pearson's correlation coeffi-
cient, and the Wilcoxon Rank-Sum test.
Results
Patients and qualatative histology
Twenty patients met the criteria for inclusion in the study, 19
with AC-RPGN. There were eight patients with anti-GBM
disease, six with no immunoglobulin deposits (NID), three with
granular, presumed IC deposits, two with microscopic polyar-
teritis nodosa type vasculitis, and one with non-crescentic
membranoproliferative GN (MPGN). The specimen from the
patient with MPGN was included in analysis of interstitial
infiltrates but not glomerular/crescentic cell composition since
she had less than 20% crescents. The histologic findings were as
previously reported [1, 2, 5, 6, 11]. In those patients with
AC-RPGN, the GN was associated with crescent formation in
20% or more glomeruli. All of the patients with RPGN had an
associated interstitial, mononuclear cell infiltrate which varied
in intensity and distribution. Many also had periglomerular
localization of mononuclear cells. The predominant cellular
infiltrates in the biopsies were lymphocytes and macrophages.
Figure 1 illustrates identical fields stained for cytotoxic/sup-
pressor lymphocytes in A, and helper-inducer lymphocytes in
B. Very lightly stained cells were not counted as T-helper
because of the small amount of cross reactivity of CD4 with
macrophages. The predominant type of cellular infiltration was
T-helper with minimal numbers of T-cytotoxic/suppressor cells.
T-cells were found not only in the interstitium, around tubules
and in a periglomerular localization as seen by H&E sections,
but also within glomeruli and crescents (Figs. 2 and 3). Macro-
phage interstitial infiltration was likewise found in these re-
gions, and was observed to localize around clusters of lympho-
cytes rather than being diffusely present throughout. Few
natural killer cells were observed in any of the tissue sections,
and B-cell infiltration was minimal.
Quantitative analysis
Five pre-implant renal transplant biopsies containing a total
of 32 glomeruli served as controls. No 1-cells, helper or
suppressor 1-cells were ever observed in any of the glomeruli.
These cells were found occasionally in the interstitium and
close to vessels but were scattered and rare. Macrophages were
occasionally observed in glomeruli and scattered in the inter-
stitium. Only two macrophages were observed in all of the
glomeruli in normal controls. Two hundred twenty—one glomer-
uli from the 19 AC-RPGN patients were available for quantita-
tive evaluation. Table I presents information on the type and
number of cells present in glomeruli and crescents of these
patients. We have presented all of these data, even when not
significant, for comparison to other investigator's work. In
patients with anti-GBM disease and vasculitis associated cres-
centic disease, it was difficult to distinguish the boundaries of
crescents relative to glomeruli, and thus few glomeruli were
clearly present for evaluation. There were few differences in the
numbers of cells present within glomeruli. Only glomerular
1-helper cells and macrophages were significantly more com-
mon in patients with anti-GBM disease than in those with NID
or IC disease. Many more crescents were evaluable for cellular
composition, yet again there were generally no differences in
the composition of the cells comprising the crescents. There
were more crescentic T-cells in patients with vasculitis than
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Fig. 1. Same field of a biopsy stained for cytotoxic/suppressor T-cells in A and helper/inducer T-cells in B. Positive cells are stained dark brown
and have pale blue nuclei, while negative cells have only pale blue nuclear staining. Most of the mononuclear infiltrating cells are T.helper
phenotype, with few T suppressor cells. Essentially all remaining cells were Leu-M3 positive macrophages, not shown. Original magnification
x 100. Publication of this color figure is provided courtesy of E.R. Squibb & Sons, Inc.
Fig. 2. Biopsy stained with CD3 for T.cells. Low power illustrating
numerous T-cells in patches and scattered within the interstitium. A
glomerulus without a crescent contains intraglomerular T-cells (arrow).
Original magnification x 100. Publication of this color figure is provided
courtesy of E. R. Squibb & Sons, Inc.
Fig. 3. Photomicrograph illustrating cells stained with pan T-cell
antiserum. Numerous T-cells are present in the interstitium, in the
periglomerular cuff, within the crescent, and capillary tuft. The limits of
the glomerular tuft and crescent are not well defined, even at high
power, and cells within the confines of Bowmans capsule are counted as
"crescentic" cells. Original magnification x 100. Publication of this
color figure is provided courtesy of E. R. Squibb & Sons, Inc.
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Table 1. Number and type of cells present, heIper/suppressor ratios, and degree of periglomerular lymphocytic infiltration
Parameter
Histologic subtypes
N GBM N NID N IC N PAN
Tgiom 4 1.2 1.2 27 0.4 0.1 22 0.9 0.5 1 2.0 —
cells/glomerulus (0—5) (0—3) (0—11) (2—2)
Hgjoi 4 9,0 1,7° 13 1.3 0.6 20 0.9 0.4 0 —
cells/glomerulus (0—13) (0—5) (0—6)
Sgiom 3 1.3 0.9 5 0.2 0.2 19 0.5 0.2 0
cells/glomerulus (0—3) (0—1) (0—4)
H/Sgiomeruiar 1 1.7 —
(1.7—1.7)
1 3.0 — 5
(3—3)
1.2 0.5
(0—2.5)
0
Bgom 0 1 0.0 0.0 8 1 0.0 0.0
cells/glomerulus (0—0) (0—0)
Mgiom 4 5.2 1.2° 20 0.6 0.3 8 1.1 0.4 0
cells/glomerulus (2—7) (0—4) (0—3)
Tcresc 77 2.1 0.4 60 1.2 0.2 26 1.3 0.6 13 2.9 10b
cells/crescent (0—18) (0—6) (0—12) (0—13)
Hcresc 69 4.8 0,6 45 3,7 0.8 17 1.8 0.5 12 3.7 2.0
cells/crescent (0—19) (0—30) (0—6) (0—24)
64 1.3 0.3 41 1.2 0.5 18 1.0 0.4 12 0.8 0,4
cells/crescent (0—10) (0—18) (0—6) (0—3)
H/Screscentic 20 1.3 0.3c
(0—4)
11 2.8 0.9 8
(0—10)
1.8 0.4
(0.3—4)
4 3.8 1.6
(0.3—8)
Bcrec 35 0.3 0.1 16 0.8 0.3 10 0.2 0.1 12 0.8 0.2
cells/crescent (0—3) (0—4) (0—1) (0—2)
Mcresc 66 4.5 0.6 58 4.2 0.7 35 2.3 0.5 11 3.0 1.8
cells/crescent (0—21) (0—22) (0—10) (0—20)
H 70 5.2 0,7b
(0—21)
54 3.4 0.7 33
(0—30)
1.5 0.4
(0—6)
12 3.7 2.0
(0—24)
S 65 1.4 0.3 45 1.1 0.4 31 0.9 0.3 12 0.8 0.4
H/S 20
(0—10)
1.3 03d
(0—4)
12
(0—18)
2.8 0.8 13
(0—10)
(0—6)
1.7 04d
(0—4)
4
(0—3)
3.8 1.6
(0—8)
M 66 4.8 0.6
(0—21)
63 4.1 0.6 39
(0—23)
2.2 0.4
(0—10)
11 3.0 1.8
(0—20)
PGL 79 0.9 0.1
(0—4)
74 0.9 0.1 41
(0—4)
0.5 0.1
(0—4)
13 0.8 0.3
(0—3)
Abbreviations are: The number of observations, N, is given immediately preceding the histologic subtype; GBM, patients with anti-GBM
disease; NID, patients with no immunoglobulin deposits; IC, patients with granular, presumed immune complex deposits; PAN, patients with
vasculitis; Tgiom, glomerular T-cells; Hgiom, glomerular T-helper cells; Sgiom, glomerular T-suppressor cells; H/Sgiom, glomerular helper/suppressor
ratio; B&om, glomerular B-cells; Mgj0m, glomerular macrophages; Cresc, crescents; Tcrec, crescentic T-cells; etc.; H = Hgiom + Hcresc S Sgiom +
Screc; H/S, helper suppressor ratio for glomeruli plus crescents; M = Mgiom + Mcresc; PGL, degrees of periglomerular lymphocytic infiltrates, 0 to
4+. The N of summed values, H, S, H/S, and M will not necessarily equal the sum of N for glomeruli plus N for crescents since a given glomerulus
with both an identifiable glomenilus and crescent will have an N of 1, not 2
a P = 0.0002 vs. NID, IC; b p < 0.05 vs. NID, IC; "P = 0.0312 vs. PAN; ii P < 0.04 vs. PAN
those with IC and NID disease. The helper:suppressor cell
ratios for crescents in patients with anti-GBM disease were
significantly less than those with vasculitis, but not different
from NID or IC. In considering the sum of glomerular and
crescentic cellular composition, helper cells were more com-
mon in anti-GBM disease than in NID and IC disease and the
helper:suppressor total ratios were lower in anti-GBM and IC
disease than in vasculitis. In all situations both in glomeruli and
in crescents the sums of helper and suppressor cells were
always greater than pan T-cells. All four subtypes of AC-RPGN
had T-cells, helper and suppressor T-cells, and macrophages
present in glomeruli as well as in crescents. B-cells were not
observed in glomeruli, but were present in very small numbers
within crescents. Analysis of the data in Table 1 by individual
biopsy revealed that the number of glomerular helper cells in
anti-GBM patients was marginally greater than the other groups
(P = 0.0499). None of the other parameters were significantly
different.
As the number of T-cells in crescents increased in anti-GBM
and immune complex disease, so also did the numbers of
T-helper or suppressor cells (Table 2). In each of the four
histologic subtypes there was a linear correlation between
increasing numbers of T-cells (as pan T or helper and suppres-
sor T cells) with increasing numbers of macrophages. Only in
NID disease was a positive correlation observed between
B-cells and T-cells and T-suppressor cells.
Thus in summary, components of the CMI system were
clearly present in the interstitium, in glomeruli, and in cres-
cents, and increasing numbers of T-cells correlated with in-
creasing numbers of macrophages. However, phenotypic char-
acterization of the cellular infiltrates was not sufficient to
distinguish the four subtypes examined.
Clinicopathologic correlations
Twelve patients responded favorably to pulse therapy while
eight did not. There were no differences in responses to therapy
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Table 2. Pearson correlations for cellular composition of crescent?
Histologic group
T-cells &
T-help
T-cells &
T-sup
T-cells
& M
T-help
& M
T-sup
& M
T-help +
T-sup & M
T-cells &
B-cells
T-sup &
B-cells
GBM
P
N of crescents
0.44
0.0005
(58)
0.30
0.0036
(40)
0.44
0.0005
(58)
0.30
0.0336
(49)
0.43
0.0006
(61)
NID
P
Nof crescents
0.43
0.0019
(49)
0.32
0.0482
(39)
0.63
0.0088
(16)
0.74
0.0034
(13)
IC
P
Nof crescents
0.61
0.01 16
(16)
0.74
0.001
(16)
0.67
0.0046
(16)
PAN
P
Nofcrescents
0.74
0.009
(11)
Abbreviations are: T-sup, T-suppressor/cytotoxic cells; T-help, T-helper/inducer cells; M, macrophage; H+S, T-helper + T-suppressor cells.
a correlation coefficient between the two cell types given in column heading
Table 3. Intensity of interstitial infiltrates and percent crescents in
individual biopsies
cells Responders Non-responders
Number of patients 12 8
Lymphocytesa
Mild 9 1
Moderate/severe 3 7
Macrophagesa
Mild 10 2
Moderate/severe 2 6
Crescents, %b 67.1 9.2 81.9 9.0
N llC 8
a p
 0.02; b P = NS; Excludes the patient with MPGN
between patients with serum creatinine above or below 6.0
mg/dl at entry into the study. The entry creatinine in responders
was 7.8 1.4 mg/dl compared to 10.0 1.0 mg/dl for non-
responders, P = NS. Five responder and two non-responder
patients had 20 to 50% crescents, while six responder and non-
responder patients each had more than 50% crescents (P =
NS). As noted previously, the one patient with MPGN had less
than 20% crescents. Eight non-responder and five of eight
responder patients with crescents were oliguric, not signifi-
cantly different (P = 0.20). The patient with MPGN was also
not oliguric despite requiring dialysis, and inclusion of that
patient in the analysis of responder for oliguria versus non-
oliguria again showed no statistical difference (P = 0.08).
Seventeen patients required dialytic support during the course
of their illness. Nine of twelve responders were dialyzed
compared to eight of eight non-responders (P = NS). Thus,
requirement for dialysis did not per se predict response or
non-response to pulse methylprednisolone therapy. On the
other hand, when response to therapy was analyzed for his-
tologic subtype, one of eight patients with anti-GBM disease
responded compared to 11 of 12 with the other subtypes (P =
0.001), and zero of seven anti-GBM patients on dialysis were
able to discontinue that support compared to nine of ten non-
anti-GBM patients on dialysis (P < 0.001).
The relationship between intensity of interstitial infiltrates
and response to therapy is presented in Table 3. Nine of 12
patients who responded to therapy had mild infiltration with
lymphocytes, and 10 of 12 responders had mild macrophage
infiltration. One of the non-responders had mild infiltrates of
lymphocytes, and two had mild infiltration with macrophages.
The percent of crescents in responder and non-responder
patients was similar. The helper/suppressor ratios of interstitial
infiltrates were not different between responder and non-re-
sponder patients (3.7 0.6 vs. 3.6 0.5). Thus, entry creati-
nine, requirement for dialysis, percent crescents, and oliguria
were not factors which significantly influenced the response to
pulse methylprednisolone therapy; the presence or absence of
anti-GBM antibody disease did influence response to therapy,
and was correlated with intensity of interstitial infiltrates which
likewise predicted responsiveness to pulse therapy.
Table 4 analyzes the mean glomerular scores for the cellular
subsets for responders and non-responders. The patient with
MPGN is excluded from crescentic analysis since she did not fit
the criteria for crescentic disease. There were no differences in
the distribution of glomeruli between responder and non-re-
sponder patients (97% chance of identical distribution, Wilcox-
on Rank-Sum test). Responders had significantly fewer num-
bers of T-helper cells within capillary tufts, crescents, and
combined tufts and crescents than non-responders. Crescentic
T-suppressor cells were likewise present in fewer numbers in
responders. Helper:suppressor ratios in crescents in respond-
ers, however, were twice as high as in non-responders, and
helper:suppressor ratios of the sum of capillary tufts plus
crescents were similarly twice as great in responders as non-
responders. Crescentic B-cells were more numerous in re-
sponders than in non-responders. The total number of macro-
phages in glomeruli, in crescents, as well as combined glomeruli
plus crescents was much greater in non-responders than in
responders. Analysis of the data in Table 4 utilizing mean
values for each of the twenty individual biopsies demonstrated
that the number of helper cells and macrophages within glomer-
uli predicted response or non-response to pulse methylprednis-
olone therapy (non-responder Hgjom 7.7 1.5 vs. 1.2 0.9 for
responders, P = 0.0099; non-responder Mgiom 4.2 1.0 V5. 0.9
0.6 for responders, P = 0.0364). Other mean parameters were
not significantly different.
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Table 4. Nu
and degree
mber and type of cells present, helper
of periglomerular lymphocytic infiltrat
and non.respondersa
/suppressor ratios,
ion in responders
N Responders N Non-responders
Tgiom
Hgioma
50 0.6 0.2
(0—11)
33 1.1 0.3
(0—6)
4
4
1,2 1.2
(0—5)
9.0 1.7
(0—13)
Sgiom 24 0.5 0.2
(0—4)
3 1.3 0.9
(0—3)
H/Sgiom 6 1.5 0.5
(0—3)
1 1.7 —
(1.7—1.7)
Bgiom 2 0.0 0.0
(0—0)
8 0.0 0.0
(0—0)
M,,," 28 0.8 0.2
(0—4)
4 5.2 1.2
(0—7)
111 1.4 0.2
(0—13)
72 2.2 0.4
(0—18)
Hcre,cb 80 3.0 0.6
(0—30)
63 5.2 0.7
(0—19)
Scre,c' 76 1.0 0,3
(0—18)
59 1.4 0.3
(0—10)
H/Screecb 23 2.6 0.5
(0—10)
20 1.3 0.3
(0—4)
Bcre,cb 33 0.7 0,2
(0—4)
40 0.3 0.1
(0—3)
Mcre,cC 108 3.1 0.4
(0—22)
62 5.2 0.6
(0—2 1)
Hb 105 2.6 0.4
(0—30)
64 5.7 0.7
(0—21)
S 93 1.0 0.2
(0—18)
60 1.5 0.3
(0—10)
H/Sb 29 2.4 0.4
(0—10)
20 1.3 0.3
(0—4)
MC 117 3.0 0.4
(0—23)
62 5.5 0.7
(0—2 1)
PGL 140 0.8 0.1
(0—4)
74 1.0 0.1
(0—4)
See Table 1 for abbreviations; the patient with MPGN is excluded.
There were thus 11 responder and 8 non-responder patients analyzed.
Data are given as cells/glomerulus, cells/crescent, ratios of cells, and
POL 0 to 4+ as described in Table 1.
a P s 0.0002; b p <oo5 C P S 0.008
Discussion
In 1984 we first demonstrated the presence of CMI compo-
nents in glomeruli and crescents of patients with RPGN, and
showed that the intensity of the CMI reaction predicted success
or failure of pulse therapy [12]. The present study extends those
findings by quantitative evaluation of nephritic kidney biopsies
with SAS program analysis, We examined the cellular compo-
sition and correlations for each glomerulus and its crescent if
present, assuming that local cellular interaction would validly
reflect dynamic CMI involvement. Since cell to cell interaction
takes place on a local level, CMI components in one glomerulus
cannot be compared with those in another, remote glomerulus.
We realize that the numbers of patients in some histologic
categories were small. Nonetheless, analysis of individual gb-
meruli should minimize this sampling size error.
Components of the CMI system were present in all biopsies,
in and around glomeruli, in crescents, and in the interstitium.
Olomerular helper cells and macrophages were more frequent
in anti-GBM disease than in NID or IC disease, but otherwise
there were no distinguishing differences in distribution of CMI
components within glomeruli. Although many more cells were
available for comparison in crescents, only vasculitis patients
had a significantly-higher helper/suppressor ratio than the other
groups. Even combining the cellular components of glomeruli
and crescents added little to the discrimination of the histologic
subtypes. B-cells were observed in crescents but not glomeruli,
and natural killer cells were not present in crescents or glomer-
uli. We always found that the sum of T-helper plus 1-suppres-
sor cells was greater than our pan-T staining. While it is
possible that the thickness of the tissue sections may have
accounted for some of the differences in number of cells present
within the same glomerulus, the presence of CD 4 + CD 8+
cells and/or natural killer cells with CD3-CD8+ phenotype is
alse possible [13]. In addition, CD4 detects some antigens on
macrophages, However, the density (70,000 to 118,000 sites/
cell less than 1% of this for macrophages) is different and we
specifically did not count lightly staining cells [14]. While CD4
has also been reported to detect certain cytoplasmic antigens in
macrophages [15], the different patterns of cellular distribution
for helpers and macrophages observed here suggest that this
contributed little to the higher total counts for helper plus
suppressor cells compared to the pan T antibody.
Few authors have observed glomerular lymphocytes of either
T-cell or B-cell variety, in contrast to the findings of the present
report. Atkins et al observed that T and B lymphocytes were
"not generally found" in glomeruli [16, 17]. Caligaris-Cappio et
a! observed no glomerular T-cells although macrophages were
present [18]. Stachura et al demonstrated numerous glomerular
1-cells [19, 20]. The majority of these T-cells were T-helper
cells and the ratio of 1-helper/suppressor in glomeruli and
interstitium was not different. Recent abstracts have described
the presence of T-cells in glomeruli of patients with a variety of
glomerular diseases and demonstrated a T-helper/suppressor
ratio of 2.7/1.8, similar to ratios reported here [21—23].
While few reports have documented the presence of 1-cells in
glomeruli, even fewer have described lymphocytes in cres-
cents, as distinct from glomeruli. Only Stachura et a! and Muller
et al have previously noted lymphocytes in crescents [20, 23].
We observed T-cells, T-helper and suppressor cells, B cells,
and macrophages within crescents.
In each histologic group macrophages were present in gb-
meruli and crescents, in the interstitium and around gbomeruli.
Macrophages were observed in close apposition to T-cells in
these locations. There was a positive association between
increasing numbers of macrophages and T-cebls in crescents,
but not with glomerular cellular infiltrates. Macrophages have
frequently been described within glomeruli and the interstitium
in GN [16, 17, 19—261. Cameron, Nolasco and Hartley [21] have
recently described heavy infiltrates in patients with various
types of ON and demonstrated that the numbers of T-cells and
macrophages in individual biopsies were correlated, as shown
here.
Interstitial infiltrates in all of our patients, including the
individual with MPGN, contained all of the components of
CMI, again with few B-cells and only rare natural killer cells.
Numerous studies have examined the characteristics of infil-
trating cells in various interstitial renal diseases and kidney
transplants using monoclonal antibodies [27—37]. In each of the
cases the cellular infiltrates were essentially all T-cells with a
CMI in RPGN: Clinicopathologic correlations 875
small percentage of B-cells. The T-helper: suppressor cell ratios
were variable depending on the underlying disease process. In
general, no specific pattern of cellular infiltration has been
defined to aid in the diagnosis of interstitial diseases.
None of the diseases in the present study, regardless of any
glomerular immune deposits, could be clearly differentiated on
the basis of the composition of glomerular, crescentic, or
interstitial components of the CMI system. This commonality
of non-differentiating characteristics in lesions of diverse etiol-
ogies suggest a pathogenetic role of CMI alone in lesions
without deposits, and a collaborative cellular/humoral interac-
tion in IC and anti-GBM disease. Although damage via the CMI
has not been directly shown by this study or any other in man,
the strong association morphologically with CMI components
provides incriminating evidence of that process, supported by
data from experimental animal models [4, 38—43J.
The second purpose of our study was to determine if the
clinical course and reponse to pulse methylprednisolone could
be correlated with the composition of CMI components present
in biopsies. To our knowledge, other investigators have not
examined the relationship between cellular composition by
monoclonal antibody and response to therapy in ON. Although
the clinicopathologic correlations in our study did not differen-
tiate between histologic types, they did provide parameters for
differentiating between responders and non-responders. Re-
sponsivity correlated highly with the degree of lymphocytic and
macrophagic interstitial infiltration. The interstitial infiltration
varied in intensity, not composition, and was not different from
that described with interstitial infiltrates unassociated with
glomerular lesions. The therapeutic unresponsivity of heavy
infiltrates extends the observations of Hooke and Atkins [44]
who demonstrated that declining renal function is closely cor-
related with the intensity of the interstitial lesions in ON.
Responsivity also correlated with fewer helper cells and mac-
rophages in glomeruli and crescents; and with lower numbers of
crescentic B-cells. Responsivity correlated in an inverse fash-
ion with the helper/suppressor ratio in crescents, and total
helper/suppressor ratios for glomeruli plus crescents. Poor
reversibility of renal allograft rejection has also been associated
with low helper:suppressor ratios and with the presence of
increased glomerular T-cells and macrophages compared to
methyiprednisolone responsive rejection [33,34,45]. In patients
treated with conventional therapy, poor prognostic factors
include an entry serum creatinine of 6 mg/dl or more, 50% or
more crescents, presence of oliguria, and requirement for
dialysis [3, 5, 6]. In the present study of patients treated with
pulse methyiprednisolone these parameters did not predict
responsivity. The presence of anti-GBM disease was associated
with non-responsivity and thus with the glomerular and cres-
centic non-responsive cellular parameters described above. It
was not possible in the present study to determine whether the
nature of the underlying disease rather than intensity and
composition of CMI involvement was the major prognostic
factor (that is, anti-GBM disease). Study of additional patients
with heavy cellular infiltrates without anti-GBM disease will be
required to differentiate this possibility.
In summary, the present study has shown that components of
CMI are present in glomeruli, crescents, and the interstitium in
the diseases that have been examined. The commonality of light
microscopic histologic findings and the presence of components
of CMI irrespective of the presence or absence of immune
deposits strongly support an etiologic role for CMI in the
pathogenesis of these types of RPGN. Although histologic
differentiation could not be accomplished on the basis of
monoclonal antibody findings, the clinical course and respon-
sivity to pulse methylprednisolone therapy was clearly associ-
ated with the degree and type of infiltration with components of
the CMI. The findings of the present study strongly suggest that
analysis of the composition of CMI system involvement in renal
biopsies of patients with RPGN can be utilized to assess
prognosis and potential for response to therapy. Independence
of these parameters relative to anti-GBM disease remains to be
clarified.
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